Global Retinal Vein Occlusion Market By Disease Type (Central Retinal Vein Occlusion (CRVO) and Branch Retinal Vein Occlusion (BRVO)), By Condition (Non-Ischemic and Ischemic), By Diagnosis- (Optical Coherence Tomography, Fundoscopic Examination, and Fluorescein Angiography), By Treatment (Anti-vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, Laser Photocoagulation, Vitrectomy and Others) and End-User (Hospital & Clinics, Ophthalmic Clinics and Ambulatory Surgical Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Feb 2025
- Report ID: 139837
- Number of Pages: 250
- Format:
-
-
-
- AbbVie Inc. Company Profile
- Hoffmann-La Roche AG
- Regeneron Pharmaceuticals, Inc.
- Taiwan Liposome Company
- Aerie Pharmaceuticals, Inc.
- Graybug Vision
- Outlook Therapeutics
- Kodiak Sciences, Inc.
- Chugai Pharmaceutical Co. Ltd.
- Novartis AG Company Profile
- Bayer AG Company Profile
- Carl Zeiss AG
- Annexin Pharmaceuticals AB (publ)
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible